Jazz Pharmaceuticals total liabilities and share holders equity for the quarter ending September 30, 2024 was $12.256B, a 9.39% increase year-over-year.
Jazz Pharmaceuticals total liabilities and share holders equity for 2023 was $11.393B, a 5.15% increase from 2022.
Jazz Pharmaceuticals total liabilities and share holders equity for 2022 was $10.835B, a 11.9% decline from 2021.
Jazz Pharmaceuticals total liabilities and share holders equity for 2021 was $12.299B, a 88.17% increase from 2020.
Jazz Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | JAZZ